A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources
NCT ID: NCT06383988
Last Updated: 2026-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
216 participants
INTERVENTIONAL
2024-11-11
2026-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Connect Oncology Needs Evaluation Tool
NCT03919864
Enhancing Lung Cancer Screening Through Human-Centered Intervention
NCT06351085
Care Coordination in Oncology, Quality Among Patients With Lung Cancer and Their Caregivers
NCT03694054
Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors
NCT06654245
The MyLungHealth Study Protocol: Engaging Patients to Enable Interoperable Lung Cancer Decision Support at Scale
NCT06338592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants (i.e., patients or care-recipients) will be asked to complete study surveys at three time points:
* After consenting and before randomization of participant and caregiver. (Initial survey)
* Approximately 12 weeks after completing the first survey (12-week survey)
* Approximately 24 weeks after completing the first survey (24-week survey)
Each survey will take about 30-45 minutes to complete. The forms will ask about things such as demographics (sex, race, etc.), cancer symptoms, satisfaction with cancer care and health behaviors. You don't have to answer any question that makes you feel uncomfortable. These surveys can be done remotely over the internet, in the clinic, by phone or by mail.
Caregivers will also complete surveys at three time points and will be assigned to 1 of 3 study groups:
* Group 1 will be given the usual care provided at your clinic. At the completion of the study, this group will be given the generic supportive care resource list for their use that Group 2 received.
* Group 2 will be provided with a generic supportive care resource list.
* Group 3 will be asked to watch a brief video and complete the web-based CONNECT program either in the clinic or on your own device. The CONNECT program is designed to help identify any unmet needs and connect the caregiver with tailored supportive care resources, based on specific needs. The CONNECT Navigator will follow-up with within 2 business days of completion of the program and again 4 weeks later.
Caregiver Participants (Group 1, 2 and 3) will be asked to complete study surveys at three time points:
* After consenting and before randomization of participant and caregiver. (Initial survey)
* Approximately 12 weeks after completing the first survey (12-week survey)
* Approximately 24 weeks after completing the first survey (24-week survey)
Each survey will take about 35-45 minutes to complete. The forms will ask about things such as demographics (sex, race, etc.), caregiving experience, use of supportive care resources, quality of life, mood, and social needs (housing, transportation, utilities, etc). You don't have to answer any question that makes you feel uncomfortable.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 3 (CONNECT, personalized list, and navigation)
Caregivers receive access to the CONNECT tool, watch an educational video on self care and receive a personalized list of resources based on caregiver preferences. Caregivers also receive access to and complete at least 2 calls, at baseline and at week 4, with a caregiver navigator to review the resource list and address any additional needs.
Support for Caregiver - Personalized List
Receive personalized resource list
Internet-Based Intervention - CONNECT
Receive access to CONNECT tool
Patient Navigation
Complete calls with caregiver navigator
Group 1 (Standard care followed by generic resource list)
Caregivers receive standard care and are then given a generic resource list at week 24.
Support for Caregiver - Generic List
Receive a generic resource list
Group 2 (Generic resource list)
Caregiver receive a generic resource list at the start of the study.
Support for Caregiver - Generic List
Receive a generic resource list
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Support for Caregiver - Generic List
Receive a generic resource list
Support for Caregiver - Personalized List
Receive personalized resource list
Internet-Based Intervention - CONNECT
Receive access to CONNECT tool
Patient Navigation
Complete calls with caregiver navigator
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must have a current diagnosis of new (i.e., initial diagnosis) or recurrent stage II-IV lung cancer
* Must be enrolled after the start of anticancer systemic therapy (+/- radiation therapy) with at least 9 weeks of any planned anticancer treatment remaining
* Must be ambulatory and up (i.e., not bedridden) more than 50% of waking hours
* Must self-report receiving informal (i.e., not professional) care from a caregiver who meets the study caregiver criteria and who is willing to participate
* Must be ≥18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
* Must self-report providing informal (i.e. not professional) care during cancer treatment for a patient who meets the patient criteria and who is willing to participate
* Must have access to the internet at home or be willing to use CONNECT in the clinic
* Must have access to telephone to complete sessions with the central caregiver navigator
Exclusion Criteria
* Enrolled in hospice care
* Unable to read and English and not willing to have someone read surveys for them
* Self-report currently receiving cancer treatment
* Unable to read and communicate in English, as the CONNECT intervention is currently only available in English
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kathryn Weaver, PhD
Role: STUDY_CHAIR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaiser Permanente-Franklin
Denver, Colorado, United States
Kaiser Permanente - Rock Creek
Lafayette, Colorado, United States
Kaiser Permanente - Lone Tree
Lone Tree, Colorado, United States
Beebe South Coastal Health Campus
Millville, Delaware, United States
Beebe Health Campus
Rehoboth Beach, Delaware, United States
Augusta University Medical Center
Augusta, Georgia, United States
Hawaii Cancer Care Inc - Waterfront Plaza
Honolulu, Hawaii, United States
Hawaii Cancer Care - Westridge
‘Aiea, Hawaii, United States
Lake Regional Hospital
Osage Beach, Missouri, United States
CoxHealth South Hospital
Springfield, Missouri, United States
Montefiore Medical Center-Einstein Campus
The Bronx, New York, United States
Wake Forest NCORP Research Base
Winston-Salem, North Carolina, United States
Community Medical Center
Scranton, Pennsylvania, United States
Geisinger Wyoming Valley/Henry Cancer Center
Wilkes-Barre, Pennsylvania, United States
Gibbs Cancer Center-Gaffney
Gaffney, South Carolina, United States
Prisma Health Cancer Institute - Butternut
Greenville, South Carolina, United States
Prisma Health Cancer Institute - Eastside
Greenville, South Carolina, United States
Gibbs Cancer Center-Pelham
Greer, South Carolina, United States
Spartanburg Medical Center
Spartanburg, South Carolina, United States
MGC Hematology Oncology-Union
Union, South Carolina, United States
ThedaCare Regional Cancer Center
Appleton, Wisconsin, United States
Aurora BayCare Medical Center
Green Bay, Wisconsin, United States
Aurora Cancer Care-Kenosha South
Kenosha, Wisconsin, United States
Aurora Saint Luke's Medical Center
Milwaukee, Wisconsin, United States
ThedaCare Regional Medical Center - Neenah
Neenah, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2023-10870
Identifier Type: OTHER
Identifier Source: secondary_id
Lead Organization Identifier
Identifier Type: OTHER
Identifier Source: secondary_id
IRB00112187
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.